Trials / Conditions / Head and Neck Neoplasm

Head and Neck Neoplasm

30 registered clinical trials studyying Head and Neck Neoplasm — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Unknown	GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results NCT05183243	Suzhou Genhouse Bio Co., Ltd.	Phase 1
Unknown	Masks Against Surface-Scanning for Radiation Therapy Immobilisation in Head and Neck Cancer (MASSC) NCT05011500	Cancer Research Antwerp	N/A
Withdrawn	Feasibility and Safety of Aerobic Exercise for Head and Neck Cancer Patients NCT04679233	Vanderbilt University	N/A
Completed	Dose-Escalated Hypofractionated Adaptive Radiotherapy for Head and Neck Cancer NCT04477759	Medical College of Wisconsin	Phase 1
Unknown	Telemedicine Nurse-Led Intervention for Rural Cancer Survivors NCT04267627	University of Virginia	N/A
Completed	Characteristics of a Maxillofacial Prosthesis Consultation Within Assistance Publique - Hopitaux de Paris NCT04277273	Assistance Publique - Hôpitaux de Paris	N/A
Recruiting	Circulating Tumor DNA (ctDNA) in Locally Advanced Head and Neck Squamous Cell Carcinoma NCT04099290	UNC Lineberger Comprehensive Cancer Center	—
Recruiting	Oropharynx (OPX) Biomarker Trial NCT06356272	Mayo Clinic	—
Completed	Analysis of Patterns of Recurrence in Head and Neck Cancer Using Clinicopathomic Markers NCT04086849	Sunnybrook Health Sciences Centre	—
Completed	Endoscopic Direct-PEG Placement in Patients Unable to Undergo Pull-PEG Procedure NCT04151030	Kansas City Veteran Affairs Medical Center	N/A
Active Not Recruiting	Randomized Study Regarding Preventive Jaw- and Swallowing Intervention for Patients With Head and Neck Cancer NCT04005521	Sahlgrenska University Hospital	N/A
Completed	Preoxygenation With a High-flow Nasal Cannula or a Simple Mask Before General Anesthesia in Head and Neck Surg NCT03896906	Asan Medical Center	N/A
Unknown	IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma. NCT03854838	Sun Yat-sen University	Phase 2
Unknown	Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal Carcinoma NCT03837808	Sun Yat-sen University	Phase 3
Active Not Recruiting	GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal Carcinoma NCT03840421	Sun Yat-sen University	Phase 3
Completed	Flexible Intubation Scope With or Without Video Laryngoscope in Supporting Endotracheal Tube Placement in Pati NCT03757091	M.D. Anderson Cancer Center	N/A
Completed	A Pilot Study of Additional Chinese Formula for Concurrent Chemoradiotherapy in Oral Cavity Cancer Patients NCT05590650	China Medical University Hospital	Phase 1
Completed	Eletric Stimulation for Hipossalivation Induced by Radiotherapy NCT03151889	Federal University of Health Science of Porto Alegre	N/A
Terminated	SBRT + Immunomodulating Systemic Therapy for Inoperable, Recurrent H&N NCT03402737	University Hospital, Ghent	N/A
Completed	Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types NCT03012581	UNICANCER	Phase 2
Completed	HARE-40: HPV Anti-CD40 RNA vaccinE NCT03418480	University of Southampton	Phase 1 / Phase 2
Completed	Supplementary Postoperative Parenteral Nutrition for Head and Neck Cancer Patients NCT03042195	University of Copenhagen	N/A
Completed	Whole-Neck Computed Tomography Perfusion Scan in Imaging Patients With Head and Neck Tumors NCT02960308	University of Southern California	—
Terminated	131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients NCT02602067	sigma-tau i.f.r. S.p.A.	Phase 1
Completed	Assessing the Patient Experience in Cancer Care NCT01621295	Mayo Clinic	—
Completed	Cetuximab as Induction Treatment in Head and Neck Squamous Cell Carcinoma (HNSCC) NCT00623558	Seoul National University Hospital	Phase 2
Terminated	Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATE NCT00423150	Merck Sharp & Dohme LLC	Phase 2
Completed	Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms NCT00666926	Verastem, Inc.	Phase 1
Completed	The Effects of Upper Airway and Digestive Tract Tumors on the Immune System NCT00001603	National Institute on Deafness and Other Communication Disorders (NIDCD)	—
Completed	A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer NCT00001442	National Cancer Institute (NCI)	Phase 1